摘要
目的探讨尿biopyrrin(Bpn)与急性心肌梗死(AMI)的相关性。方法选择190例AMI患者,分别在患者初入院、再灌注治疗后、治疗后24 h、治疗后48 h检测患者尿Bpn水平,同时检测年龄、性别差异无统计学意义的健康对照者(健康对照组)200例。结果 AMI患者尿Bpn高于健康对照组,再灌注治疗后尿Bpn显著升高,48 h后恢复至正常水平。结论尿Bpn与AMI呈正相关,测定尿Bpn有助于预测AMI及AMI再灌注治疗后的疗效。
Objective To study the relationship between urinary biopyrrin levels and AMI. Methods 190 patients with AMI disease,which were identified by AMI within 1. 5 year（from January 2008 year to June 2009 year）were chosen as observation group, They were divided into five groups according to the time of thrombolytie therapy, and 200 age and sex matched controls were selected from healthy examinees. The levels of biopyrrin were determined by enzyme-linked immunosorbent assay in thise cases. Resuits Compared with the controls,The level of biopyrrin in urine were all significantly raised in patients with AMI and thrombolytie therapy（P〈0.05）. Conclusion Biopyrrin is significantly associated with AMI. and showed a positive correlation with the effect of thrombolytic therapy,
出处
《国际检验医学杂志》
CAS
2011年第2期189-189,191,共2页
International Journal of Laboratory Medicine
关键词
心肌梗死
再灌注
相关性
mycardial infarction
resperfasion
relationgship
